To my knowledge, the closest thing we have to a trial schedule is their latest presentation, and we know that some of the trials shown in it haven't begun because of discussions from the company.

To me the biggest mystery is the fibromyalgia trial. If you look at the presentation it began last year. I don't know if that was the case, nor do I know if it was done with patients who have the disease. In short, I'm aware of nothing about the trial except for the fact that it shows in the presentation. To me it's not even clear if it's being done with the cream, the sublingual tablet, or a combination that employs both of them.

I've been involved in other companies that limited what was said about their trials, but all the protocols were posted in the clinical trials database. Those companies were criticized by investors for not providing enough, and that's always a complaint, but by comparison with OWCP, they were firehosing us with information.

If the company would routinely update the entire presentation, investors would have many of their questions answered. They've done some minor changes, but didn't address the changes in the timeline, so I don't view those changes as complete updates, they merely documented personnel changes.

Gary